These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 27912793

  • 1. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
    Ziegelasch M, van Delft MA, Wallin P, Skogh T, Magro-Checa C, Steup-Beekman GM, Trouw LA, Kastbom A, Sjöwall C.
    Arthritis Res Ther; 2016 Dec 03; 18(1):289. PubMed ID: 27912793
    [Abstract] [Full Text] [Related]

  • 2. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
    Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, Segal MS, Hahn PC, Chan EK, Reeves WH, Satoh M.
    J Rheumatol; 2009 Dec 03; 36(12):2682-90. PubMed ID: 19884269
    [Abstract] [Full Text] [Related]

  • 3. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
    Li Y, Jia R, Liu Y, Tang S, Ma X, Shi L, Zhao J, Hu F, Li Z.
    Lupus; 2020 Mar 03; 29(3):239-247. PubMed ID: 31930936
    [Abstract] [Full Text] [Related]

  • 4. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
    Zhao Y, Li J, Li XX, Li C, Li L, Li ZG.
    Joint Bone Spine; 2009 Oct 03; 76(5):501-7. PubMed ID: 19289297
    [Abstract] [Full Text] [Related]

  • 5. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C, Zofotă S, Bojincă V, Ionescu R.
    Rom J Intern Med; 2013 Oct 03; 51(3-4):179-87. PubMed ID: 24620631
    [Abstract] [Full Text] [Related]

  • 6. Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?
    Taraborelli M, Inverardi F, Fredi M, Ceribelli A, Cavazzana I, Tincani A, Franceschini F.
    Reumatismo; 2012 Dec 11; 64(5):321-5. PubMed ID: 23256108
    [Abstract] [Full Text] [Related]

  • 7. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF, Zhang QB, Zhou JG, Yuan GH, Wei J, Xing Y, Liu JP, Jiang L, Chen JP.
    Lupus; 2009 Jul 11; 18(8):713-7. PubMed ID: 19502267
    [Abstract] [Full Text] [Related]

  • 8. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
    Wagner CA, Sokolove J, Lahey LJ, Bengtsson C, Saevarsdottir S, Alfredsson L, Delanoy M, Lindstrom TM, Walker RP, Bromberg R, Chandra PE, Binder SR, Klareskog L, Robinson WH.
    Ann Rheum Dis; 2015 Mar 11; 74(3):579-86. PubMed ID: 24297382
    [Abstract] [Full Text] [Related]

  • 9. Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients.
    Skare TL, Nisihara R, Barbosa BB, da Luz A, Utiyama S, Picceli V.
    Clin Rheumatol; 2013 Jul 11; 32(7):1065-70. PubMed ID: 23412637
    [Abstract] [Full Text] [Related]

  • 10. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
    Alessandri C, Bartosiewicz I, Pendolino M, Mancini R, Colasanti T, Pecani A, Morello F, Mastrangelo A, Sabatinelli D, Riccieri V, Di Franco M, Ceccarelli F, Perricone C, Conti F, Valesini G.
    Clin Exp Rheumatol; 2015 Jul 11; 33(6):824-30. PubMed ID: 26411477
    [Abstract] [Full Text] [Related]

  • 11. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
    Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ.
    J Rheumatol; 2008 Jan 11; 35(1):77-83. PubMed ID: 18085741
    [Abstract] [Full Text] [Related]

  • 12. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D.
    Ann Rheum Dis; 2014 Oct 11; 73(10):1761-8. PubMed ID: 24812286
    [Abstract] [Full Text] [Related]

  • 13. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
    Damián-Abrego GN, Cabiedes J, Cabral AR.
    Lupus; 2008 Apr 11; 17(4):300-4. PubMed ID: 18413411
    [Abstract] [Full Text] [Related]

  • 14. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.
    J Rheumatol; 2004 Sep 11; 31(9):1829-33. PubMed ID: 15338508
    [Abstract] [Full Text] [Related]

  • 15. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H, Trouw LA, Sokolove J, Lahey LJ, Huizinga TJ, Smolik IA, Robinson DB, El-Gabalawy HS, Toes RE, Hitchon CA.
    Arthritis Rheumatol; 2016 Sep 11; 68(9):2090-8. PubMed ID: 26946484
    [Abstract] [Full Text] [Related]

  • 16. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D.
    Arthritis Rheum; 2013 Apr 11; 65(4):911-5. PubMed ID: 23279976
    [Abstract] [Full Text] [Related]

  • 17. Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
    Ceccarelli F, Perricone C, Colasanti T, Massaro L, Cipriano E, Pendolino M, Natalucci F, Mancini R, Spinelli FR, Valesini G, Conti F, Alessandri C.
    Arthritis Res Ther; 2018 Jun 14; 20(1):126. PubMed ID: 29898764
    [Abstract] [Full Text] [Related]

  • 18. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status.
    Ball EM, Tan AL, Fukuba E, McGonagle D, Grey A, Steiner G, Bell AL, Rooney MR.
    Rheumatology (Oxford); 2014 Oct 14; 53(10):1835-43. PubMed ID: 24850876
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
    Martinsson K, Johansson A, Kastbom A, Skogh T.
    Clin Exp Immunol; 2017 Apr 14; 188(1):53-62. PubMed ID: 27859022
    [Abstract] [Full Text] [Related]

  • 20. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
    Challener GJ, Jones JD, Pelzek AJ, Hamilton BJ, Boire G, de Brum-Fernandes AJ, Masetto A, Carrier N, Ménard HA, Silverman GJ, Rigby WFC.
    J Rheumatol; 2016 Feb 14; 43(2):273-281. PubMed ID: 26669911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.